Skip to main content
. 2016 May 6;5(6):469–479. doi: 10.1002/cpdd.256

Figure 3.

Figure 3

Simulated apremilast concentration‐versus‐time profiles (mean and 90%CI) in psoriatic arthritis subjects with (thick orange lines and shaded area) and without (blue lines and shaded area) severe renal impairment following oral administration of apremilast at 30 mg once daily and 30 mg twice daily.